ArticleFrontiers in oncology2021

Cryptotanshinone Inhibits ERα-Dependent and -Independent BCRP Oligomer Formation to Reverse Multidrug Resistance in Breast Cancer.

Wenting Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.